Objective To evaluate sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like
peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying …

Background The comparative efficacy and safety of pharmacological agents to lower blood
pressure in adults with diabetes and kidney disease remains controversial. We aimed to …

Importance Numerous glucose-lowering drugs are used to treat type 2 diabetes. Objective
To estimate the relative efficacy and safety associated with glucose-lowering drugs including …

BACKGROUND:: Sexual dysfunction is an under-recognized problem in men and women with
chronic kidney disease (CKD). The prevalence, correlates, and predictors of this condition …

Results A total of seven studies involving 15,285 participants were included. Healthy dietary
patterns were generally higher in fruit and vegetables, fish, legumes, cereals, whole grains, …

Background Managing the complex fluid and diet requirements of chronic kidney disease (CKD)
is challenging for patients. We aimed to summarize patients’ perspectives of dietary and …

Background Oral disease may be increased in people with chronic kidney disease (CKD)
and, due to associations with inflammation and malnutrition, represents a potential modifiable …

Background Guidelines preferentially recommend noncalcium phosphate binders in adults
with chronic kidney disease (CKD). We compare and rank phosphate-binder strategies for …

Background Dietary changes are routinely recommended in people with chronic kidney
disease (CKD) on the basis of randomised evidence in the general population and non‐…

Background Phosphate binders are used to reduce positive phosphate balance and to
lower serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …